Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
King's College London Business Ltd is responsible for commercialisation of technologies emanating from King's. Opportunities include: Collaborative & Contract research, Consultancy, Clinical trials. More
Therapure Biopharma Inc develops, manufactures, fills and packages complex high-quality biological therapeutics. More
WORLDiscoveries™ is the new Business Development arm of London’s extensive Research network and the bridge between local invention and global industry. More
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
Pharmaceutical sales to the UK hospital market. More
LIBBS is now searching for new in-licensing or co-marketing opportunities for the territory of Brazil in key areas like Cardiology, CNS, HRT, Contraception, GI, Dermatology, Respiratory and Oncology. More
The Italian National Institute of Health (ISS) is the main technical-scientific organ of the Ministry of health and the highest public healthcare research entity in Italy. More
LBN was established in June 2000, providing the first co-ordinated approach to biotechnology in London. With over 2000 members, LBN is now one of the largest biotechnology networks in Europe. More
Probiodrug develops low-molecular weight organic molecules that modulate the activity of certain proteins as potential drugs. More
Your selection
Browse By
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us